IMPEDIMED LIMITED — Capital/Financing Update 2020

Mar 29, 2020

Market Announcement

==> picture [33 x 50] intentionally omitted <==

30 March 2020

==> picture [451 x 5] intentionally omitted <==

ImpediMed Limited (ASX: IPD) – Trading Halt (2+2)

Description

The securities of ImpediMed Limited (‘IPD’) will be placed in trading halt at IPD’s request, pending it releasing an announcement about the outcome of the institutional component of the accelerated entitlement offer. Unless ASX decides otherwise, the securities will remain in trading halt until the commencement of normal trading on Friday, 3 April 2020.

Issued by

Corey Lian

Adviser, Listings Compliance (Sydney)

Market Announcement 1/1 ASX Customer Service Centre 131 279 | asx.com.au

30 March 2020 ASX Limited

==> picture [216 x 69] intentionally omitted <==

30 March 2020

Mr Corey Lian Listings Compliance ASX Compliance Pty Ltd 20 Bridge Street Sydney NSW 2000

Dear Mr Lian,

Pursuant to ASX Listing Rule 17.1, ImpediMed Limited (ASX: IPD) ( ImpediMed ) requests an immediate trading halt be granted by ASX Limited with respect to its shares, to apply from the commencement of trading on Monday, 30 March 2020 , until the earlier of ImpediMed making an announcement regarding the outcome of the institutional component of an accelerated nonrenounceable entitlement offer ( Offer ) and the commencement of trading on Friday, 03 April 2020.

The trading halt is requested in connection with a capital raising.

The following information is provided in accordance with Listing Rule 17.1:

1. Reason for trading halt – to avoid trading taking place on an uninformed basis and to allow the Offer to take place in an orderly manner.

2. Duration of the trading halt – ImpediMed requests that the trading halt remain in place until the earlier of ImpediMed making an announcement to ASX concerning the outcome of the institutional component of the Offer and the commencement of trading on Friday, 03 April 2020.

3. No reason – ImpediMed is not aware of any reason why the trading halt should not be granted.

4. Further information – none.

Should you have any questions, please do not hesitate to contact me on +61 414 731 082.

Yours sincerely, Leanne Ralph Company Secretary

ImpediMed Ltd ● ABN 65 089 705 144 ● TEL: +61 (0)7 3860 3700 FAX: 61 (0)7 3260 1225 ● FREE CALL: 1800 638 477 ● EMAIL: enquiries@impedimed.com